[1]
Diani Nur Pathona 2026. THE ROLE OF SODIUM–GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS IN REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS : A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES. The International Journal of Medical Science and Health Research. 48, 5 (Aug. 2026), 135–230. DOI:https://doi.org/10.70070/dver3926.